Johnson & Johnson

J&J strikes US states deal over baby powder claims

Johnson & Johnson offers $9bn to settle talc claims

Johnson & Johnson to stop selling talcum powder

Investors lose vote to share Covid vaccine know-how

Drug maker bonuses threatened over vaccine access

Opioid crisis: US drug giants reach $26bn settlement

Drugs giant to pay $230m to settle opioid claim

US court rejects J&J talc cancer case appeal

Ireland approves rollout of further Covid-19 jabs

Very low blood clot risk from J&J jab – EU experts

Johnson & Johnson: Billion Covid-19 jabs in a year. Video, 00:05:24Johnson & Johnson: Billion Covid-19 jabs in a year

Biden: Enough vaccine for all in US by end of May

Single-shot Covid-19 vaccine approved in US

Single-shot Covid-19 vaccine 'safe and effective'

Single-dose Johnson & Johnson jab is 66% effective

Johnson & Johnson loses vaginal mesh class action

Asbestos discovery triggers US baby powder recall

Man wins $8bn court case over breast growth

Johnson & Johnson settles over opioids with Ohio

Johnson & Johnson fined in landmark opioid ruling

Johnson & Johnson in billion-dollar opioid trial

The hottest business stories of 2018

Asbestos report hits Johnson & Johnson shares